title: Treatment outcomes of various types of tuberculosis in Pakistan, 2006 and 2007.
abstract: Measuring treatment outcome is important for successful tuberculosis (TB) control programmes. The purpose of this study was to examine the outcomes of various types of TB cases registered in Pakistan over a 2-year period and compare those outcomes among the different provinces and regions of the country. A retrospective, cohort study was conducted in which TB treatment outcome reports were reviewed. Of the 349 694 pulmonary TB cases registered in Pakistan during 2006 and 2007, 309154 (88.4%) were treated successfully. Treatment success was significantly higher in new smear-positive cases and lower in retreatment cases. Among the provinces and regions, treatment success was significantly higher in 4 out of 8 provinces. Treatment success needs to be improved, particularly in retreatment cases. The national TB control programme should review the provincial and regional programmes and learn lessons from well-performing programmes. Patient factors that may affect the treatment outcome should be also studied.
authors: A A
authors: AA
authors: Chughtai
authors: C R
authors: CR
authors: MacIntyre
authors: Y A
authors: YA
authors: Wang
authors: Z
authors: Z
authors: Gao
authors: W
authors: W
authors: Khan
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D023801:Directly Observed Therapy; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000706:statistics & numerical data*; D010154:Pakistan / Q000453:epidemiology; D011159:Population Surveillance / Q000379:methods; D012008:Recurrence; D012042:Registries; D012111:Residence Characteristics / Q000145:classification; D012189:Retrospective Studies; D016896:Treatment Outcome; D014376:Tuberculosis / Q000145:classification / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents